HTMwire
Velentium logo

Velentium

FDA Compliance Tools

HTMwire assessment

Velentium (Velentium Medical) is an engineering-first partner providing integrated medical device development, manufacturing, and cybersecurity services for Class II and Class III devices. Its cybersecurity practice spans risk identification through implementation, positioned alongside product development and test systems from concept to commercialization.

Key Features

  • Medical device development and manufacturing
  • Device cybersecurity services
  • Class II and III device expertise
  • Automated test systems

What Sets Them Apart

Cybersecurity delivered as part of full Class II/III medical device development and manufacturing services.

How Velentium Uses AI

No AI/ML

HTMwire's independent read on the technology — not the vendor's marketing claim.

Tags

medical-device-development device-cybersecurity fda-compliance engineering-services class-ii-iii

Frequently Asked Questions

What does Velentium do for HTM and device teams?

Velentium (Velentium Medical) is an engineering-first partner providing integrated medical device development, manufacturing, and cybersecurity services for Class II and Class III devices. Its cybersecurity practice spans risk identification through implementation, positioned alongside product development and test systems from concept to commercialization.

What makes Velentium different?

Velentium's differentiator is delivering cybersecurity as part of full Class II/III medical device development and manufacturing services rather than as a standalone tool. The company was founded in 2012 and is headquartered in Houston, TX.

Does Velentium use AI?

No, Velentium does not market an AI or ML capability. Its cybersecurity is delivered as engineering and development services alongside device manufacturing and automated test systems.

Sources

  1. Velentium Medical — medical device development and cybersecurity services

We cite a primary or named source for every claim on this page. How we evaluate →

Last updated: June 8, 2026